Cyclosporin A in combination with HAART in primary HIV-1 infection

Journal of Biological Regulators and Homeostatic Agents

Volumn 14, Issue 1, 2000, Pages 79-81

  Rizzardi, G P ^a   Vaccarezza, M ^a   Capiluppi, B ^a   Tambussi, G ^a   Lazzarin, A ^a   Pantaleo, G ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cyclosporin A; HAART; HIV eradication; Immune based strategies; Immunosuppression; Primary HIV 1 infection

Indexed keywords

ANTIRETROVIRUS AGENT; CYCLOSPORIN A; IMMUNOMODULATING AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DRUG WITHDRAWAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFECTION CONTROL; LONG TERM CARE; MORBIDITY; MORTALITY; PRIMARY INFECTION; SIDE EFFECT;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034457544     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. The AIDS epidemic-considerations for the 21st century
2. Update: Trends in AIDS incidence - United States, 1996
3. Update: Trends in AIDS incidence, deaths, and prevalence-United States, 1996
4. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
5. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
6. Identification of a reservoir for HIV-1 in patients on highly active antifretroviral therapy
7. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
8. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy
9. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
10. Can HIV be eradicated?
11. Decay characteristics of HIV-1-infected compartments during combination therapy
12. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
13. Immunopathogenesis of HIV infection
14. Therapeutic perspectives in HIV-1 infection from recent advances in HIV-1 pathogenesis: It is time to move on
15. Vigorous HIV-1 specific CD4+ T cell responses associated with control of viremia
16. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV
17. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
18. lymphocytes as an inducible virus reservoir in HIV-1-infection
19. The effects of cyclosporin A on the immune system
20. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells
21. Nuclear import of HIV-1 DNA in resting CD4+ T cells requires a cyclosporin A-sensitive pathway
22. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells
23. Ongoing HIV dissemination during HAART
24. Cyclosporin A modulation of early virologic and immunologic events during primary simian immunodeficiency virus infection in rhesus monkeys
25. Cyclosporine induces cancer progression by a cell-autonomous mechanism
26. Does cyclosporin A cause cancer?